Recent Press Releases

Phosphate Therapeutics Selects Clinipace Worldwide to Manage its Phase 2 Renal Study

MORRISVILLE, N.C.--()--Clinipace Worldwide, a global digital clinical research organization (dCRO), announced today that Phosphate Therapeutics, co-owned and resourced by Shield...

DaVita Clinical Research and Pyxant Labs to Collaborate on Clinical Trials

MINNEAPOLIS, Feb. 12, 2014 /PRNewswire-USNewswire/ -- DaVita Clinical Research® (DCR®), a specialty contract research organization with services spanning the full spectrum of drug and device...

Theorem Clinical Research and Decision Driver Analytics Form Strategic Alliance

KING OF PRUSSIA, Pa.--()--Theorem Clinical Research has announced the formation of a strategic alliance with Decision Driver Analytics (DDA) that will integrate health economics and...

Chiltern Partners With Karolinska Development

LONDON and WILMINGTON, N.C., Feb. 12, 2014 /PRNewswire/ -- Chiltern International Limited (Chiltern), a global contract research organization (CRO), proudly announces our partnership with Karolinska...

Quintiles Reports Fourth Quarter 2013 Results

$1.0 billion of service revenues in the fourth quarter; First billion dollar service revenue quarter in Quintiles' history Net new business wins of $1.3 billion representing a book-to-bill...

AMRI Announces Fourth Quarter and Full Year 2013 Results and Provides 2014 Guidance

ALBANY, N.Y., Feb. 12, 2014 /PRNewswire/ -- AMRI (NASDAQ: AMRI) today reported financial and operating results for the fourth quarter and full year ended December 31, 2013. Fourth Quarter and Full...

PAREXEL Rebrands Its Technology Subsidiary PAREXEL Informatics; Retains Perceptive Brand For Service Offerings

BOSTON, Feb. 12, 2014 /PRNewswire/ -- PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that Perceptive Informatics, the PAREXEL...

PAREXEL Simplifies Drug Development Journey From Science To New Treatments

Boston, MA, February 12, 2014 — As the global biopharmaceutical industry increasingly seeks to streamline the complex process of bringing new drugs to market, PAREXEL International Corporation...

Charles River Laboratories Announces Fourth-Quarter and Full-Year 2013 Results from Continuing Operations and Provides 2014 Guidance

– Fourth-Quarter Sales of $289.2 Million and Full-Year 2013 Sales of $1.17 Billion – – Fourth-Quarter GAAP Earnings per Share of $0.40 and Non-GAAP Earnings per Share of $0.73...

Theorem Clinical Research and Decision Driver Analytics Form Strategic Alliance

Theorem Clinical Research and Decision Driver Analytics Form Strategic Alliance (King of Prussia, PA; Feb. 11, 2014) Theorem Clinical Research has announced the formation of a strategic...

ISR Projects the 2014 CRO Market to Be Worth $23.6 Billion

CARY, NC-- Industry Standard Research (ISR) has announced the availability of a new report titled "2014 CRO Market Size Projections: 2012-2018." For this report, ISR has utilized both...

University of Edinburgh and Selcia in £2.5 m Bid to Develop New Drugs to Target Sleeping Sickness

An initiative is under way to develop new drugs for a devastating tropical disease that threatens almost 70 million people in Africa. Scientists are beginning a £2.5 million project to design...

BioClinica Grows eClinical Results in Europe

BioClinica®, Inc., the global provider of clinical trial management solutions, today announced that Europe was the fastest growing geographic region in 2013 for its eClinical technology...

BioOutsource To Open New Biosimilar Centre of Excellence in Glasgow as Global Demand Surges

Glasgow, Scotland – BioOutsource Ltd. ("BioOutsource"), a global leader in biologics contract testing and biosimilar characterization for the biopharmaceutical industry, today...

Covance Reports Fourth Quarter Net Revenue Of $623 Million, Pro Forma EPS Of $0.87 And Adjusted Net Orders Of $769 Million

PRINCETON, N.J. -- Covance Inc. (NYSE: CVD) today reported results for its fourth quarter and year ended December 31, 2013. Net revenue in the fourth quarter was $623.1 million, representing 10.8%...

Translational Imaging Center to Speed Drug Development, Lower Costs

Translational Imaging Center to Speed Drug Development, Lower Costs First-of-its-Kind Facility to Begin Operations in Early Spring Mattawan, MICH., February 4, 2014 - MPI Research, inviCRO, and 3D...

THERAMetrics holding AG (SIX: TMX) announces its 2014 corporate calendar and provides preliminary guidance for its 4th quarter 2013 results

Stans, Switzerland, February 4, 2014 - THERAMetrics Holding AG announces its 2014 corporate calendar and provides preliminary guidance for its 4th quarter 2013 results. The THERAMetrics Board of...